Abstract
Within 4 hours after i.v. administration (5 or 50 mg/kg) of 14C-ethacrynic acid (EA), 60 to 70% was excreted into the bile of rats. Less than 25% was EA and the remainder was biotransformation products. The two major metabolites in bile were identified; one was the glutathione adduct of EA (EA-GSH) and the other was EA-mercapturate. Approximately 40% of either dose was excreted as EA-GSH. EA-mercapturate accounted for 18% of the low dose and 30% of the high dose excreted into bile. Dogs excreted 57% of a 5 mg/kg dose (i.v.) into bile within 4 hours. Less EA was metabolized by the dog than the rat; 38% of the radioactivity excreted into dog bile was in the form of the parent drug. In addition to the two metabolites of EA found in rat bile, the dog formed a cysteine adduct of EA (EA-cysteine). The dog excreted 25, 11 and 9% of the dose of EA as EA-mercapturate, EA-cysteine and EA-GSH, respectively. Seventeen percent of the 14C excreted into the bile remained unidentified.
Footnotes
- Received May 6, 1974.
- Accepted August 1, 1974.
- © 1974 by The Williams & Wilkins Co.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
